Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Comparison of dopamine and norepinephrine in the treatment of shock.

De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; SOAP II Investigators.

N Engl J Med. 2010 Mar 4;362(9):779-89. doi: 10.1056/NEJMoa0907118.

2.

Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.

Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, Balk RA.

Shock. 2010 Apr;33(4):375-80. doi: 10.1097/SHK.0b013e3181c6ba6f.

PMID:
19851126
3.

Dopamine versus norepinephrine in the treatment of shock.

Nathan Coxford R, Lang E, Dowling S.

CJEM. 2011 Nov;13(6):395-7. doi: 10.2310/8000.2011.110297.

PMID:
22436478
4.

Vasopressin versus norepinephrine infusion in patients with septic shock.

Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators.

N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373.

5.

Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.

Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.

Pharmacotherapy. 2004 Aug;24(8):1002-12.

PMID:
15338849
6.

Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.

Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troché G, Ricard JD, Nitenberg G, Papazian L, Azoulay E, Bellissant E; CATS Study Group.

Lancet. 2007 Aug 25;370(9588):676-84. Erratum in: Lancet. 2007 Sep 22;370(9592):1034.

PMID:
17720019
7.

Effect of norepinephrine on the outcome of septic shock.

Martin C, Viviand X, Leone M, Thirion X.

Crit Care Med. 2000 Aug;28(8):2758-65.

PMID:
10966247
8.

Comparison of dopamine and norepinephrine in shock.

Romero CM.

N Engl J Med. 2010 Jun 17;362(24):2328; author reply 2330-1. doi: 10.1056/NEJMc1003900. No abstract available.

9.

Treating shock--old drugs, new ideas.

Levy JH.

N Engl J Med. 2010 Mar 4;362(9):841-3. doi: 10.1056/NEJMe1000091. No abstract available.

PMID:
20200389
10.

Terlipressin in the treatment of late phase catecholamine-resistant septic shock.

Svoboda P, Scheer P, Kantorová I, Doubek J, Dudra J, Radvan M, Radvanova J.

Hepatogastroenterology. 2012 Jun;59(116):1043-7. doi: 10.5754/hge10550.

PMID:
22580654
11.

Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).

Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC; Portuguese Community-Acquired Sepsis Study Group.

Crit Care Med. 2009 Feb;37(2):410-6. doi: 10.1097/CCM.0b013e3181958b1c.

PMID:
19114885
12.

Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.

Vasu TS, Cavallazzi R, Hirani A, Kaplan G, Leiby B, Marik PE.

J Intensive Care Med. 2012 May-Jun;27(3):172-8. doi: 10.1177/0885066610396312. Epub 2011 Mar 24. Review.

PMID:
21436167
13.

Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?

De Backer D, Creteur J, Silva E, Vincent JL.

Crit Care Med. 2003 Jun;31(6):1659-67.

PMID:
12794401
14.

Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.

Schmoelz M, Schelling G, Dunker M, Irlbeck M.

J Cardiothorac Vasc Anesth. 2006 Apr;20(2):173-8. Epub 2006 Feb 21.

PMID:
16616656
15.

Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.

De Backer D, Aldecoa C, Njimi H, Vincent JL.

Crit Care Med. 2012 Mar;40(3):725-30. doi: 10.1097/CCM.0b013e31823778ee.

PMID:
22036860
16.

Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.

Valverde E, Pellicer A, Madero R, Elorza D, Quero J, Cabañas F.

Pediatrics. 2006 Jun;117(6):e1213-22. Epub 2006 May 22.

PMID:
16717120
17.

Adrenergic vasopressor agents and mechanical ventilation for the treatment of experimental septic shock.

Tang W, Pakula JL, Weil MH, Noc M, Fukui M, Bisera J.

Crit Care Med. 1996 Jan;24(1):125-30.

PMID:
8565517
18.

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K.

Crit Care Med. 1999 Apr;27(4):723-32.

PMID:
10321661
19.

Controversies regarding choice of vasopressor therapy for management of septic shock in animals.

Silverstein DC, Beer KA.

J Vet Emerg Crit Care (San Antonio). 2015 Jan-Feb;25(1):48-54. doi: 10.1111/vec.12282. Review.

PMID:
25655726
20.

Beneficial effects of short-term vasopressin infusion during severe septic shock.

Patel BM, Chittock DR, Russell JA, Walley KR.

Anesthesiology. 2002 Mar;96(3):576-82.

PMID:
11873030

Supplemental Content

Support Center